Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fentanyl controlled-release - Valerio Therapeutics

Next Previous
Drug Profile

Fentanyl controlled-release - Valerio Therapeutics

Alternative Names: BA-041; Fentanyl Lauriad

Latest Information Update: 08 Sep 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioAlliance Pharma
  • Developer Valerio Therapeutics
  • Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Cancer pain

Highest Development Phases

  • Discontinued Cancer pain

Most Recent Events

  • 03 Sep 2014 Discontinued - Phase-I/II for Cancer pain (In volunteers) in France (Buccal)
  • 01 Aug 2014 TopoTarget has merged with BioAlliance Pharma to form Onxeo SA
  • 07 Oct 2010 Fentanyl controlled-release - BioAlliance Pharma is available for licensing as of 07 Oct 2010. www.bioalliancepharma.com

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top